about
Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerAutomatized assessment of 1p36-19q13 status in gliomas by interphase FISH assay on touch imprints of frozen tumours.Sunitinib combined with angiotensin-2 type-1 receptor antagonists induces more necrosis: a murine xenograft model of renal cell carcinoma.Micro-cost Analysis of ALK Rearrangement Testing by FISH to Determine Eligibility for Crizotinib Therapy in NSCLC: Implications for Cost Effectiveness of Testing and TreatmentClinicopathological characteristics of ROS1- and RET-rearranged NSCLC in caucasian patients. Data from a cohort of 713 non-squamous NSCLC lacking KRAS/EGFR/HER2/BRAF/PIK3CA/ALK alterations.Array-CGH diagnosis in ovarian failure: identification of new molecular actors for ovarian physiology.MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11).Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential.Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death.Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): a feasibility study.FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients.The relative levels of cyclin D1a and D1b alternative transcripts in mantle cell lymphoma may depend more on sample origin than on CCND1 polymorphism.Comparison of human embryomorphokinetic parameters in sequential or global culture media.Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas.Karyotype is not dead (yet)!Postnatal diagnosis of 9q interstitial imbalances involving PTCH1, resulting from a familial intrachromosomal insertion.Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases.Terminal 6.9 Mb deletion of chromosome 15q, associated with a structurally abnormal X chromosome in a patient with congenital diaphragmatic hernia and heart defect.Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival.[Angiotensin-2 type 1 receptors (AT1R) and cancers].Involvement of germline DDX1-MYCN duplication in inherited nephroblastoma.Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy.Clinical and molecular delineation of Tetrasomy 9p syndrome: report of 12 new cases and literature review.Parallel FISH and immunohistochemical studies of ALK status in 3244 non-small-cell lung cancers reveal major discordances.All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study.Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.Whole genome duplication is an early event leading to aneuploidy in -wild type glioblastoma
P50
Q26996829-589E9E59-E456-4EB6-AC1F-529B215C1EDEQ33232891-27FF98FF-3EA0-4EA9-9077-5F9F5E21821BQ33745382-96F80011-6176-4BE5-96A7-9BCF96D496E0Q34662576-19B81EA8-30B7-43EB-A95B-536770A22E3AQ36411528-16256BCA-ACC6-4FF5-A987-6411D29AA677Q37307656-582E8822-64ED-406E-AEBC-CF6E78943A16Q38110943-6852AF89-4FFA-4901-9AE9-6A3E89FA3BD6Q39252478-DE6FC4FE-51AD-40DE-8F68-0E0C2A4A5972Q39395931-AC7DADDF-ABC4-49E2-94C1-7D038A54346FQ39555398-711C4E6D-9A55-4B5B-90AE-9CA8CD8FC8A5Q41597806-95D22375-EFE3-4208-85A8-FD0D5B1A8BC2Q41822859-3920DFC7-5CED-4286-9C4A-081B251BDC92Q46541971-25CF379E-BFCD-460A-B0CD-455243402D6DQ47311127-FEB3A41E-EDBE-4EDD-9DB2-2DE18EB79DC5Q47420563-3153BB24-6760-471D-859A-1F5D3641CC45Q48896502-C5FD6B63-1DB4-456F-80EC-58797899FF7AQ50691616-83D3A5D5-D423-444A-A978-9D8328842F4CQ51011386-CF51E96B-953F-4ABE-ACA1-B203343C44F1Q51530739-3578D4E1-48CA-42F5-B1C9-F6D56A04B533Q51532661-56BFEFB5-028D-4858-B004-28B9AB141558Q51625377-69C041B1-58ED-49EB-8E41-96F56C8D30B2Q53048445-D748C420-F661-4229-84BA-ED6D4A3476F5Q53112942-4A152FF3-E016-4F76-B238-0F8B8B26B239Q53247392-10831C70-DA99-456C-9418-F9724AC4993AQ53263432-4039E966-0B72-416B-BE73-0E88047E0528Q53804048-CB239A78-F6B3-4EFF-A968-CF2027C43E66Q54378153-0093B320-2B06-4785-A458-A87CC97DABEEQ54494865-8B973982-8983-43E3-89C5-35F5E16E9DFDQ54544092-D5B83356-5598-469B-8D86-8E860887C53EQ54569561-A14A284F-49F5-4D23-9447-15B7DB2FFDC6Q59809195-3C9ACFFF-A217-4B14-88A8-58A3F812FB90
P50
description
onderzoeker
@nl
name
Marc-Antoine Belaud-Rotureau
@af
Marc-Antoine Belaud-Rotureau
@an
Marc-Antoine Belaud-Rotureau
@ast
Marc-Antoine Belaud-Rotureau
@bar
Marc-Antoine Belaud-Rotureau
@br
Marc-Antoine Belaud-Rotureau
@ca
Marc-Antoine Belaud-Rotureau
@co
Marc-Antoine Belaud-Rotureau
@cs
Marc-Antoine Belaud-Rotureau
@cy
Marc-Antoine Belaud-Rotureau
@da
type
label
Marc-Antoine Belaud-Rotureau
@af
Marc-Antoine Belaud-Rotureau
@an
Marc-Antoine Belaud-Rotureau
@ast
Marc-Antoine Belaud-Rotureau
@bar
Marc-Antoine Belaud-Rotureau
@br
Marc-Antoine Belaud-Rotureau
@ca
Marc-Antoine Belaud-Rotureau
@co
Marc-Antoine Belaud-Rotureau
@cs
Marc-Antoine Belaud-Rotureau
@cy
Marc-Antoine Belaud-Rotureau
@da
prefLabel
Marc-Antoine Belaud-Rotureau
@af
Marc-Antoine Belaud-Rotureau
@an
Marc-Antoine Belaud-Rotureau
@ast
Marc-Antoine Belaud-Rotureau
@bar
Marc-Antoine Belaud-Rotureau
@br
Marc-Antoine Belaud-Rotureau
@ca
Marc-Antoine Belaud-Rotureau
@co
Marc-Antoine Belaud-Rotureau
@cs
Marc-Antoine Belaud-Rotureau
@cy
Marc-Antoine Belaud-Rotureau
@da